NCT07152990

Brief Summary

CAPNOSOH study is a single-center study conducted at Toulouse University Hospital, aiming to estimate the prevalence of obese and apneic subjects maintaining nocturnal hypoventilation under continuous positive airway pressure (CPAP).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
139

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Sep 2025May 2027

First Submitted

Initial submission to the registry

August 25, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 3, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

September 3, 2025

Status Verified

August 1, 2025

Enrollment Period

1.7 years

First QC Date

August 25, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

Nocturnal hypoventilationobesitysleep apnea syndromecontinuous positive pressuretranscutaneous capnography

Outcome Measures

Primary Outcomes (1)

  • Prevalence of nocturnal alveolar hypoventilation

    Prevalence of nocturnal alveolar hypoventilation will be diagnosed by transcutaneous oxy-capnography. Nocturnal alveolar hypoventilation is defined with PTcCO2 \> 49 mmHg more than 10% of the time of capnographic recording.

    1 month

Study Arms (1)

Obese Patients with Obstructive Sleep Apnea/Hypopnea

OTHER
Other: Transcutaneous Oxy-CapnographyOther: Quality of life questionnairesOther: Arterial gasometryOther: Body plethysmographyOther: Spirometry with reversibility testOther: Clinical examination

Interventions

Patients will be monitored using transcutaneous oxy-capnography to evaluate the prevalence of nocturnal alveolar hypoventilation in these population. Nocturnal alveolar hypoventilation is defined with PTcCO2 \> 49 mmHg more than 10% of the time of capnographic recording.

Obese Patients with Obstructive Sleep Apnea/Hypopnea

Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, and the "Patient-Reported Hypoventilation Questionnaire".

Obese Patients with Obstructive Sleep Apnea/Hypopnea

Arterial blood gas analysis will be performed only in patients presenting nocturnal hypoventilation.

Obese Patients with Obstructive Sleep Apnea/Hypopnea

Plethysmography will be performed only in patients presenting nocturnal hypoventilation. It will be used to measure lung volume and assess pulmonary function. This non-invasive procedure involves the patient breathing into a device that measures changes in pressure within a sealed chamber.

Obese Patients with Obstructive Sleep Apnea/Hypopnea

The intervention will be performed only in patients presenting nocturnal hypoventilation. Spirometry with a reversibility test will be performed to assess lung function and evaluate the response to bronchodilators. The procedure involves measuring forced expiratory volume and forced vital capacity before and after the administration of a bronchodilator.

Obese Patients with Obstructive Sleep Apnea/Hypopnea

Clinical exam will be performed only in patients presenting nocturnal hypoventilation. It will consists of standard interview/clinical examination: vital signs, cardiological, pulmonary, abdominal, neurological examination, search for clinical signs of nocturnal hypoventilation, search for signs of hypoxia/hypercapnia, pulmonary auscultation.

Obese Patients with Obstructive Sleep Apnea/Hypopnea

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obese patients (Body Mass Index \> 30 kg/m2)
  • Fitted by one of the following providers: ASTEN, Vitalaire, Orkyn, ISIS, RespiO2, BASTIDE for \> 3 months with compliance of more than 4 consecutive hours per night in average during 3 months
  • "Good quality" criteria for continuous positive airway pressure (CPAP) treatment: compliance \> 4 consecutive hours per night, unintentional leaks \< limit defined by the manufacturer, residual AHI \< 10/h
  • Aged 18 to 80
  • Affiliated or beneficiaries of the social security system or equivalent
  • Having given written informed consent
  • Able to understand instructions and information given

You may not qualify if:

  • Patient under legal protection measure
  • Non-compliant patients
  • Pregnant or breast-feeding women (assessed on questioning)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Toulouse Hôpital Larrey

Toulouse, Occitanie, 31059, France

Location

MeSH Terms

Conditions

ObesitySleep Apnea, ObstructiveSleep Apnea Syndromes

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative Techniques

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All patients will undergo transcutaneous oxy-capnography and answer quality of life questionnaires. Only patients presenting nocturnal hypoventilation defined with PTcCO2 \> 49 mmHg more than 10% of the time of capnographic recording will continue the study with additional interventions. Patients without nocturnal hypoventilation will finish the study after the capnographic recording visit.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2025

First Posted

September 3, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

September 3, 2025

Record last verified: 2025-08

Locations